NCT06212388 2024-01-25Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection MelanomaXijing HospitalPhase EARLY_PHASE1 Not yet recruiting10 enrolled